Cargando…

Genotype and phenotype of salt-stimulated paraoxonase 1 (PON1) is associated with atherogenic indices in type 2 diabetes

BACKGROUND: Paraoxonase 1 (PON1) and lipid abnormalities contribute to the development of cardiovascular disease, which is the principal cause of mortality in patients with type 2 diabetes (T2D). Data are not available on the potential association between salt-stimulated activity of PON1 (PON1-salt)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qujeq, Durdi, Mahrooz, Abdolkarim, Alizadeh, Ahad, Masoumi, Parisa, Annemohammadzadeh, Saleh, Boorank, Ruzbeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154515/ https://www.ncbi.nlm.nih.gov/pubmed/30288380 http://dx.doi.org/10.1007/s40200-018-0332-z

Ejemplares similares

Paraoxonase-2 variants potentially influence insulin resistance, beta-cell function, and their interrelationships with alanine aminotransferase in type 2 diabetes
por: Qujeq, Durdi, et al.
Publicado: (2018)

Paraoxonase 1 Activity is Associated with Interleukin-6 Levels in Type 2 Diabetes: Effects of Age and Gender
por: Nikzad, Armin, et al.
Publicado: (2023)

Paraoxonase 1 (PON1) Q192R genotypes and their interaction with smoking strongly increase atherogenicity and the Framingham risk score
por: de Souza-Nogueira, Andre, et al.
Publicado: (2016)

The Atherogenic Index Log (Triglyceride/HDL-Cholesterol) as a Biomarker to Identify Type 2 Diabetes Patients with Poor Glycemic Control
por: Nosrati, Mani, et al.
Publicado: (2021)

Lead Exposure Is Associated with Decreased Serum Paraoxonase 1 (PON1) Activity and Genotypes
por: Li, Wan-Fen, et al.
Publicado: (2006)

Serum paraoxonase 1 (PON1) measurement: an update
por: Ceron, Jose J, et al.
Publicado: (2014)

Alzheimer’s Disease and Paraoxonase 1 (PON1) Gene Polymorphisms
por: Saeidi, Mohsen, et al.
Publicado: (2017)

Paraoxonases (PON) 1, 2, and 3 Polymorphisms and PON-1 Activities in Patients with Sickle Cell Disease
por: Reichert, Cadiele Oliana, et al.
Publicado: (2019)

Paraoxonase (PON1 and PON3) Polymorphisms: Impact on Liver Expression and Atorvastatin-Lactone Hydrolysis
por: Riedmaier, Stephan, et al.
Publicado: (2011)

Paraoxonase-1 (PON1) promoter region polymorphisms, serum PON1 status and coronary heart disease
por: Mackness, Bharti, et al.
Publicado: (2013)

The Role of Metformin Response in Lipid Metabolism in Patients with Recent-Onset Type 2 Diabetes: HbA1c Level as a Criterion for Designating Patients as Responders or Nonresponders to Metformin
por: Kashi, Zahra, et al.
Publicado: (2016)

Effects of Intronic and Exonic Polymorphisms of Paraoxonase 1 (PON1) Gene on Serum PON1 Activity in a Korean Population
por: Eom, Sang-Yong, et al.
Publicado: (2011)

Racial Differences in Paraoxonase-1 (PON1): A Factor in the Health of Southerners?
por: Davis, Kimberly A., et al.
Publicado: (2009)

Serial measurements of Paraoxonase-1 (PON-1) activity in horses with experimentally induced endotoxemia
por: Scavone, Donatella, et al.
Publicado: (2020)

O Gene da Paraoxonase 1 (PON1) no Contexto Doença Arterial Coronariana
por: Pinheiro, Denise da Silva, et al.
Publicado: (2022)

Role of paraoxonase 1 activity and PON1 gene polymorphisms in sickle cell disease
por: Menezes, Joelma Figueiredo, et al.
Publicado: (2023)

Human Paraoxonase-2 (PON2): Protein Functions and Modulation
por: Manco, Giuseppe, et al.
Publicado: (2021)

The effect of paraoxonase 1 (PON1) gene polymorphisms T(-107)C and L55M and diet composition on serum PON1 activity in women
por: Zanini, Bianka Machado, et al.
Publicado: (2021)

Two common nonsynonymous paraoxonase 1 (PON1) gene polymorphisms and brain astrocytoma and meningioma
por: Martínez, Carmen, et al.
Publicado: (2010)

Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine
por: Ünsal, Cüneyt, et al.
Publicado: (2013)

Sex Difference Impacts on the Relationship between Paraoxonase-1 (PON1) and Type 2 Diabetes
por: Rosta, Valentina, et al.
Publicado: (2020)

Influence of nutritional factors and the PON1 C(-107)T polymorphism on paraoxonase-1 activity in childhood()
por: Sigales, Tainá S., et al.
Publicado: (2019)

Paraoxonase (PON)-1: a brief overview on genetics, structure, polymorphisms and clinical relevance
por: Shunmoogam, Nelusha, et al.
Publicado: (2018)

Risk of Brain Tumors in Children and Susceptibility to Organophosphorus Insecticides: The Potential Role of Paraoxonase (PON1)
por: Nielsen, Susan Searles, et al.
Publicado: (2005)

Paraoxonase 1 (PON1) Polymorphisms, Haplotypes and Activity in Predicting CAD Risk in North-West Indian Punjabis
por: Gupta, Nidhi, et al.
Publicado: (2011)

Age-Dependent Paraoxonase 1 (PON1) Activity and LDL Oxidation in Wistar Rats during Their Entire Lifespan
por: Kumar, Dileep, et al.
Publicado: (2014)

Ticagrelor induces paraoxonase-1 (PON1) and better protects hypercholesterolemic mice against atherosclerosis compared to clopidogrel
por: Halim, Hasseri, et al.
Publicado: (2019)

Paraoxonase-1 Serum Concentration and PON1 Gene Polymorphisms: Relationship with Non-Alcoholic Fatty Liver Disease
por: Milaciu, Mircea Vasile, et al.
Publicado: (2019)

Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-Analysis
por: Zuin, Marco, et al.
Publicado: (2022)

Depletion of Paraoxonase 1 (Pon1) Dysregulates mTOR, Autophagy, and Accelerates Amyloid Beta Accumulation in Mice
por: Witucki, Łukasz, et al.
Publicado: (2023)

A PON for All Seasons: Comparing Paraoxonase Enzyme Substrates, Activity and Action including the Role of PON3 in Health and Disease
por: Mohammed, Chrysan J., et al.
Publicado: (2022)

Interactome of Paraoxonase PON2 Reveals New Pathways for Tumor Growth Regulation
por: Karlov, V. D., et al.
Publicado: (2023)

A High Throughput Serum Paraoxonase Assay for Discovery of Small Molecule Modulators of PON1 Activity
por: Graves, Tiffany L, et al.
Publicado: (2008)

Levothyroxine improves Paraoxonase (PON-1) serum levels in patients with primary hypothyroidism: Case–control study
por: Al-Naimi, Marwa S., et al.
Publicado: (2018)

Effects of aerobic training on serum paraoxonase activity and its relationship with PON1-192 phenotypes in women
por: Nalcakan, Gulbin Rudarli, et al.
Publicado: (2016)

Association of M55L and Q192R polymorphisms of paraoxonase 1 gene (PON1) with recurrent pregnancy loss risk: A case–control study
por: Alizadeh, Mehdi, et al.
Publicado: (2021)

Allele frequency and genotype distribution of a common variant in the 3´-untranslated region of the SLC22A3 gene in patients with type 2 diabetes: Association with response to metformin
por: Ghaffari-Cherati, Maryam, et al.
Publicado: (2016)

Serum Cholinesterase Inhibition in Relation to Paraoxonase-1 (PON1) Status among Organophosphate-Exposed Agricultural Pesticide Handlers
por: Hofmann, Jonathan N., et al.
Publicado: (2009)

Association between Paraoxonase 1 (PON1) Polymorphisms and the Risk of Acute Coronary Syndrome in a North African Population
por: Bounafaa, Abdelghani, et al.
Publicado: (2015)

Association between pesticide exposure and paraoxonase-1 (PON1) polymorphisms, and neurobehavioural outcomes in children: a systematic review
por: Banhela, Nkosinathi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hv113vqj70id83urreivsdstii